During a press conference at the White House, Gordon Findlay, a Novo Nordisk executive, suddenly collapsed while standing behind President Donald Trump. The event marked the announcement of a new weight-loss medication deal by the Trump administration.
Findlay's knees buckled unexpectedly, causing him to fall. Administration officials and pharmaceutical representatives quickly intervened to prevent him from hitting the floor. On-site medical staff arrived promptly to provide assistance.
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, helped Findlay to the ground to protect his head from injury. Following the collapse, reporters were asked to leave the Oval Office as cabinet members attended to Findlay and elevated his legs.
The press secretary confirmed that Findlay was okay and the conference would soon continue as planned.
Summary: A Novo Nordisk executive fainted during a White House event announcing a weight-loss medication deal, but swift medical intervention ensured his quick recovery and continuation of the press conference.